Skip to content
2000
Volume 32, Issue 11
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Cataract remains one of the leading causes of blindness worldwide. Studies have shown that its onset is predominantly age-related, particularly affecting the elderly. According to the latest report by the World Health Organization (WHO), more than fifty percent of global blindness cases are attributed to cataracts alone. If timely and appropriate measures are not implemented, this percentage is projected to double in the coming decades. Therefore, there is an urgent need to develop alternative approaches to manage cataracts more effectively, beyond the current reliance on surgical intervention. In recent years, researchers have been actively exploring simpler, non-surgical treatment options that could potentially dissolve cataracts in their early stages. The successful development of such therapies would mark a significant breakthrough and offer immense benefits to humanity. This article highlights the evolution of surgical techniques used in cataract management, from traditional practices to modern innovations, while also discussing emerging non-invasive strategies such as lanosterol-based pharmacotherapy, nanomedicine-driven drug delivery systems, and regenerative approaches like stem cell therapy. These advances signal a promising future for safer, more accessible, and more effective cataract care.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128409580250812000816
2025-10-09
2026-03-01
Loading full text...

Full text loading...

References

  1. FlaxmanS.R. BourneR.R.A. ResnikoffS. Global causes of blindness and distance vision impairment 1990-2020: A systematic review and meta-analysis.Lancet Glob. Health2017512e1221e123410.1016/S2214‑109X(17)30393‑5 29032195
    [Google Scholar]
  2. SteinmetzJ.D. BourneR.R.A. BriantP.S. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The right to sight: An analysis for the Global burden of disease study.Lancet Glob. Health202192e144e16010.1016/S2214‑109X(20)30489‑7 33275949
    [Google Scholar]
  3. HeruyeS.H. NkenyiL.N.M. SinghN.U. Current trends in the pharmacotherapy of cataracts.Pharmaceuticals20201311510.3390/ph13010015 31963166
    [Google Scholar]
  4. PesudovsK. LansinghV.C. KempenJ.H. Global estimates on the number of people blind or visually impaired by cataract: A meta-analysis from 2000 to 2020.Eye (Lond.)202438112156217210.1038/s41433‑024‑02961‑1 38461217
    [Google Scholar]
  5. DelbarreM. Froussart-MailleF. Signs, symptoms, and clinical forms of cataract in adults.J. Fr. Ophtalmol.202043765365910.1016/j.jfo.2019.11.009 32586638
    [Google Scholar]
  6. NarteyA. The pathophysiology of cataract and major interventions to retarding its progression: A mini review.Adv Ophthal Visual Syst201763767810.15406/aovs.2017.06.00178
    [Google Scholar]
  7. SolomonR. DonnenfeldE.D. Recent advances and future frontiers in treating age-related cataracts.JAMA2003290224825110.1001/jama.290.2.248 12851280
    [Google Scholar]
  8. WangL. LiX. MenX. LiuX. LuoJ. Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review).Mol. Med. Rep.20243112210.3892/mmr.2024.13387 39513587
    [Google Scholar]
  9. AscasoF.J. CristóbalJ.A. The oldest cataract in the Nile Valley.J. Cataract Refract. Surg.200127111714171510.1016/S0886‑3350(01)01205‑6 11709231
    [Google Scholar]
  10. BassnettS. ShiY. VrensenG.F.J.M. Biological glass: Structural determinants of eye lens transparency.Philos. Trans. R. Soc. Lond. B Biol. Sci.201136615681250126410.1098/rstb.2010.0302 21402584
    [Google Scholar]
  11. AsbellP. DualanI. MindelJ. BrocksD. AhmadM. EpsteinS. Age-related cataract.Lancet2005365945959960910.1016/S0140‑6736(05)70803‑5 15708105
    [Google Scholar]
  12. DonaldsonP.J. GreyA.C. HeilmanB.M. LimJ.C. VaghefiE. The physiological optics of the lens.Prog. Retin. Eye Res.201756e1e2410.1016/j.preteyeres.2016.09.002 27639549
    [Google Scholar]
  13. ThrimawithanaT.R. RupenthalI.D. RäschS.S. LimJ.C. MortonJ.D. BuntC.R. Drug delivery to the lens for the management of cataracts.Adv. Drug Deliv. Rev.201812618519410.1016/j.addr.2018.03.009 29604375
    [Google Scholar]
  14. Pastor-ValeroM. FletcherA.E. de StavolaB.L. Chaqués-AlepúzV. Years of sunlight exposure and cataract: A case-control study in a Mediterranean population.BMC Ophthalmol.2007711810.1186/1471‑2415‑7‑18 18039367
    [Google Scholar]
  15. DrinkwaterJ.J. DavisW.A. DavisT.M.E. A systematic review of risk factors for cataract in type 2 diabetes.Diabetes Metab. Res. Rev.2019351e307310.1002/dmrr.3073 30209868
    [Google Scholar]
  16. LindbladB.E. HåkanssonN. WolkA. Smoking cessation and the risk of cataract: A prospective cohort study of cataract extraction among men.JAMA Ophthalmol.2014132325325710.1001/jamaophthalmol.2013.6669 24385206
    [Google Scholar]
  17. XuY. LiangA. ZhengX. Sex-specific social, lifestyle, and physical health risk factors in cataracts development.Eye (Lond.)202438152939294610.1038/s41433‑024‑03193‑z 39075262
    [Google Scholar]
  18. SmeethL. BoulisM. HubbardR. FletcherA.E. A population based case-control study of cataract and inhaled corticosteroids.Br. J. Ophthalmol.200387101247125110.1136/bjo.87.10.1247 14507760
    [Google Scholar]
  19. YadavA. ChoudharyR. BodakheS.H. Role of nitric oxide in the development of cataract formation in CdCl2-induced hypertensive animals.Curr. Eye Res.201843121454146410.1080/02713683.2018.1501490 30015520
    [Google Scholar]
  20. AscasoF.J. LizanaJ. CristóbalJ.A. Cataract surgery in ancient Egypt.J. Cataract Refract. Surg.200935360760810.1016/j.jcrs.2008.11.052 19251160
    [Google Scholar]
  21. BohačM. JagićM. Introductory Chapter: Refractive Surgery.Refractive Surgery-Types of Procedures, Risks, and Benefits.IntechOpen202210.5772/intechopen.104578
    [Google Scholar]
  22. GrzybowskiA. AscasoF.J. Sushruta in 600 B.C. introduced extraocular expulsion of lens material.Acta Ophthalmol.201492219419710.1111/aos.12037 23464869
    [Google Scholar]
  23. ErdurmuşM. SimavlıH. AydınB. Cataracts: An Overview.Handbook of Nutrition, Diet, and the Eye201910.1016/b978‑0‑12‑815245‑4.00014‑4
    [Google Scholar]
  24. DavisG. The evolution of cataract surgery.Mo. Med.201611315862 27039493
    [Google Scholar]
  25. DeanW. Sandford-SmithJ. Eye surgery in hot climates.4th edJP Medical Publishers2015
    [Google Scholar]
  26. ShielsA. HejtmancikJ.F. Biology of inherited cataracts and opportunities for treatment.Annu. Rev. Vis. Sci.20195112314910.1146/annurev‑vision‑091517‑034346 31525139
    [Google Scholar]
  27. KumariS.S. GandhiJ. MustehsanM.H. ErenS. VaradarajK. Functional characterization of an AQP0 missense mutation, R33C, that causes dominant congenital lens cataract, reveals impaired cell-to-cell adhesion.Exp. Eye Res.201311637138510.1016/j.exer.2013.09.019 24120416
    [Google Scholar]
  28. BlomstedtP. Cataract surgery in ancient Egypt.J. Cataract Refract. Surg.201440348548910.1016/j.jcrs.2014.01.006 24485861
    [Google Scholar]
  29. RuanX. LiuZ. LuoL. LiuY. Structure of the lens and its associations with the visual quality.BMJ Open Ophthalmol.202051e00045910.1136/bmjophth‑2020‑000459 33024825
    [Google Scholar]
  30. ChangM.A. CongdonN.G. BakerS.K. BloemM.W. SavageH. SommerA. The surgical management of cataract: Barriers, best practices and outcomes.Int. Ophthalmol.200828424726010.1007/s10792‑007‑9121‑2 17712529
    [Google Scholar]
  31. GreinerJ.V. ChylackL.T. Posterior subcapsular cataracts: Histopathologic study of steroid-associated cataracts.Arch. Ophthalmol.1979971135144
    [Google Scholar]
  32. SpencerR.W. AndelmanS.Y. Steroid cataracts, posterior subcapsular cataract formation in rheumatoid arthritis patients on long term steroid therapy.Arch. Ophthalmol.1965743841
    [Google Scholar]
  33. LefflerC.T. KlebanovA. SamaraW.A. GrzybowskiA. The history of cataract surgery: From couching to phacoemulsification.Ann. Transl. Med.2020822155110.21037/atm‑2019‑rcs‑04 33313296
    [Google Scholar]
  34. TingD.S.W. TanS. LeeS.Y. RosmanM. AwA.T. YeoI.Y.S. Extracapsular cataract extraction training: Junior ophthalmology residents’ self-reported satisfaction level with their proficiency and initial learning barrier.Postgrad. Med. J.201591107736837210.1136/postgradmedj‑2014‑132961 26060314
    [Google Scholar]
  35. ChenY. YeZ. ChenH. LiZ. Breaking barriers: Nanomedicine-based drug delivery for cataract treatment.Int. J. Nanomedicine2024194021404010.2147/IJN.S463679 38736657
    [Google Scholar]
  36. LiuY SongD ZhangG A novel electromagnetic driving system for 5-DOF manipulation in intraocular microsurgery.Cyborg Bionic Syt20245410.34133/cbsystems.0083
    [Google Scholar]
  37. DawoodY.F. IssaA.F. AliS.S.M. Changes in anterior chamber biometry and intraocular pressure after uneventful phacoemulsification in non-glaucomatous eyes.Med. Hypothesis Discov. Innov. Ophthalmol.2023121283510.51329/mehdiophthal1467 37641670
    [Google Scholar]
  38. JiangZ. ChenZ. XuY. Low-frequency ultrasound sensitive Piezo1 channels regulate keloid-related characteristics of fibroblasts.Adv. Sci. (Weinh.)20241114e230548910.1002/advs.202305489
    [Google Scholar]
  39. GuptaS.K. SelvanV.K. AgrawalS.S. SaxenaR. Advances in pharmacological strategies for the prevention of cataract development.Indian J. Ophthalmol.200957317518310.4103/0301‑4738.49390 19384010
    [Google Scholar]
  40. CastroviejoR. Theoretical and practical study of the intracapsular cataract extraction.Am. J. Ophthalmol.193215540641610.1016/S0002‑9394(32)92645‑2
    [Google Scholar]
  41. GoJ.A. MamalisC.A. KhandelwalS.S. Cataract surgery considerations for diabetic patients.Curr. Diab. Rep.202121126710.1007/s11892‑021‑01418‑z 34967932
    [Google Scholar]
  42. HoffmanR.S. Braga-MeleR. DonaldsonK. Cataract surgery and nonsteroidal antiinflammatory drugs.J. Cataract Refract. Surg.20164291368137910.1016/j.jcrs.2016.06.006 27697257
    [Google Scholar]
  43. ChenX. XuJ. ChenX. YaoK. Cataract: Advances in surgery and whether surgery remains the only treatment in future.Adv. Ophthalmol. Pract. Res.20211110000810.1016/j.aopr.2021.100008 37846393
    [Google Scholar]
  44. AwadA.A. AlkorbiH.A. Abu SerhanH. Charles Kelman: The Father of Phacoemulsification.Cureus2024166e61727 38975537
    [Google Scholar]
  45. BoulterT. BernhiselA. MamalisC. Phacoemulsification in review: Optimization of cataract removal in an in vitro setting.Surv. Ophthalmol.201964686887510.1016/j.survophthal.2019.06.007 31276738
    [Google Scholar]
  46. HoffmanR.S. FineI.H. PackerM. New phacoemulsification technology.Curr. Opin. Ophthalmol.2005161384310.1097/00055735‑200502000‑00007 15650578
    [Google Scholar]
  47. MartínezM.B. MoyanoD.B. González-LezcanoR.A. Phacoemulsification: proposals for improvement in its application.Health Care2021911160310.3390/healthcare9111603
    [Google Scholar]
  48. BatlleJ.F. LansinghV.C. SilvaJ.C. EckertK.A. ResnikoffS. The cataract situation in Latin America: Barriers to cataract surgery.Am. J. Ophthalmol.20141582242250.e110.1016/j.ajo.2014.04.019 24792101
    [Google Scholar]
  49. ChanC.C. Couching for cataract in China.Surv. Ophthalmol.201055439339810.1016/j.survophthal.2010.02.001 20451942
    [Google Scholar]
  50. KanellopoulosA.J. AsimellisG. Standard manual capsulorhexis/ultrasound phacoemulsification compared to femtosecond laser-assisted capsulorhexis and lens fragmentation in clear cornea small incision cataract surgery.Eye Vis. (Lond.)2016312010.1186/s40662‑016‑0050‑x 27478858
    [Google Scholar]
  51. SugaiS. YoshitomiF. OshikaT. Transconjunctival single-plane sclerocorneal incisions versus clear corneal incisions in cataract surgery.J. Cataract Refract. Surg.20103691503150710.1016/j.jcrs.2010.03.045 20692562
    [Google Scholar]
  52. AlióJ. ElkadyB. OrtizD. Corneal optical quality following sub 1.8 mm micro-incision cataract surgery vs. 2.2 mm mini-incision coaxial phacoemulsification.Middle East Afr. J. Ophthalmol.2010171949910.4103/0974‑9233.61225 20543945
    [Google Scholar]
  53. CavalliniG.M. VerdinaT. ForliniM. Long-term follow-up for bimanual microincision cataract surgery: Comparison of results obtained by surgeons in training and experienced surgeons.Clin. Ophthalmol.201610979987 27307701
    [Google Scholar]
  54. ShentuX. ZhangX. TangX. YuX. Coaxial microincision cataract surgery versus standard coaxial small-incision cataract surgery: A meta-analysis of randomized controlled trials.PLoS One2016111e014667610.1371/journal.pone.0146676 26745279
    [Google Scholar]
  55. HelvaciogluF. TuncZ. YeterC. OguzhanH. SencanS. Ozil IP torsional mode versus combined torsional/longitudinal microcoaxial phacoemulsification.Eur. J. Ophthalmol.201222693694210.5301/ejo.5000136 22427146
    [Google Scholar]
  56. AssilK. HarrisL. CeckaJ. Transverse vs. torsional ultrasound: Prospective randomized contralaterally controlled study comparing two phacoemulsification-system handpieces.Clin. Ophthalmol.201591405141110.2147/OPTH.S86660 26345628
    [Google Scholar]
  57. NagyZ. New technology update: Femtosecond laser in cataract surgery.Clin. Ophthalmol.201481157116710.2147/OPTH.S36040 24970994
    [Google Scholar]
  58. DownieL.E. BusijaL. KellerP.R. Blue-light filtering intraocular lenses (IOLs) for protecting macular health.Cochrane Libr.201820185CD01197710.1002/14651858.CD011977.pub2 29786830
    [Google Scholar]
  59. PackerM. FineI.H. HoffmanR.S. Aspheric intraocular lens selection: The evolution of refractive cataract surgery.Curr. Opin. Ophthalmol.20081911410.1097/ICU.0b013e3282f2d791 18090888
    [Google Scholar]
  60. BauerN.J.C. de VriesN.E. WebersC.A.B. HendrikseF. NuijtsR.M.M.A. Astigmatism management in cataract surgery with the AcrySof toric intraocular lens.J. Cataract Refract. Surg.20083491483148810.1016/j.jcrs.2008.05.031 18721707
    [Google Scholar]
  61. de VriesN.E. NuijtsR.M.M.A. Multifocal intraocular lenses in cataract surgery: Literature review of benefits and side effects.J. Cataract Refract. Surg.201339226827810.1016/j.jcrs.2012.12.002 23332253
    [Google Scholar]
  62. OngH.S. EvansJ.R. AllanB.D.S. Accommodative intraocular lens versus standard monofocal intraocular lens implantation in cataract surgery.Cochrane Libr.201420145CD00966710.1002/14651858.CD009667.pub2 24788900
    [Google Scholar]
  63. SunH. FritzA. DrögeG. NeuhannT. BilleJ.F. Femtosecond-Laser-Assisted Cataract Surgery (FLACS). In: BilleJF, Ed. High resolution imaging in microscopy and ophthalmology: New Frontiers in Biomedical Optics,Springer Copyright 2019, The Author(s). Cham, CH: Springer20193011710.1007/978‑3‑030‑16638‑0_14
    [Google Scholar]
  64. NarayanA. EvansJ.R. O’BrartD. BunceC. GoreD.M. DayA.C. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.Cochrane Database Syst. Rev.202366CD010735 37369549
    [Google Scholar]
  65. RobertsH.W. DayA.C. O’BrartD.P.S. Femtosecond laser–assisted cataract surgery: A review.Eur. J. Ophthalmol.202030341742910.1177/1120672119893291 31801354
    [Google Scholar]
  66. GrewalD.S. SchultzT. BastiS. DickH.B. Femtosecond laser–assisted cataract surgery—current status and future directions.Surv. Ophthalmol.201661210313110.1016/j.survophthal.2015.09.002 26409902
    [Google Scholar]
  67. LiS. JieY. Cataract surgery and lens implantation.Curr. Opin. Ophthalmol.2019301394310.1097/ICU.0000000000000547 30335627
    [Google Scholar]
  68. KałuznyJ. KałuznyB.J. Microincision cataract surgery.Klin. Oczna20051077-9426430 16416989
    [Google Scholar]
  69. DeweyS. BeikoG. Braga-MeleR. NixonD.R. RavivT. RosenthalK. Microincisions in cataract surgery.J. Cataract Refract. Surg.20144091549155710.1016/j.jcrs.2014.07.006 25135548
    [Google Scholar]
  70. AlióJ.L. SoriaF. AbdouA.A. Peña-GarcíaP. Fernández-BuenagaR. JavaloyJ. Comparative outcomes of bimanual MICS and 2.2-mm coaxial phacoemulsification assisted by femtosecond technology.J. Refractive Surg.2014303440
    [Google Scholar]
  71. HuT. MengS. LiuC. LCN2 deficiency mitigates the neuroinflammatory damage following acute glaucoma.Theranostics20251572967299010.7150/thno.104752 40083945
    [Google Scholar]
  72. WeikertM.P. Update on bimanual microincisional cataract surgery.Curr. Opin. Ophthalmol.2006171626710.1097/01.icu.0000193069.32369.e1 16436926
    [Google Scholar]
  73. YangJ. WangX. ZhangH. PangY. WeiR.H. Clinical evaluation of surgery-induced astigmatism in cataract surgery using 2.2 mm or 1.8 mm clear corneal micro-incisions.Int. J. Ophthalmol.20171016871 28149779
    [Google Scholar]
  74. ElkadyB. PiñeroD. AlióJ.L. Corneal incision quality: Microincision cataract surgery versus microcoaxial phacoemulsification.J. Cataract Refract. Surg.200935346647410.1016/j.jcrs.2008.11.047 19251139
    [Google Scholar]
  75. GutierrezL. LimJ.S. FooL.L. Application of artificial intelligence in cataract management: Current and future directions.Eye Vis. (Lond.)202291310.1186/s40662‑021‑00273‑z 34996524
    [Google Scholar]
  76. GohJ.H.L. LimZ.W. FangX. Artificial Intelligence for cataract detection and management.Asia Pac. J. Ophthalmol. (Phila.)202092889510.1097/01.APO.0000656988.16221.04 32349116
    [Google Scholar]
  77. LindeggerD.J. WawrzynskiJ. SalehG.M. Evolution and applications of artificial intelligence to cataract surgery.Ophthalmol. Sci.20222310016410.1016/j.xops.2022.100164 36245750
    [Google Scholar]
  78. TongY. LuW. YuY. ShenY. Application of machine learning in ophthalmic imaging modalities.Eye Vis. (Lond.)2020712210.1186/s40662‑020‑00183‑6 32322599
    [Google Scholar]
  79. SonK.Y. KoJ. KimE. Deep learning-based cataract detection and grading from slit-lamp and retro-illumination photographs.Ophthalmol. Sci.20222210014710.1016/j.xops.2022.100147 36249697
    [Google Scholar]
  80. NespoloR.G. YiD. ColeE. ValikodathN. LucianoC. LeidermanY.I. Evaluation of Artificial Intelligence–based intraoperative guidance tools for phacoemulsification cataract surgery.JAMA Ophthalmol.2022140217017710.1001/jamaophthalmol.2021.5742 35024773
    [Google Scholar]
  81. BatesA. Clarity unveiled: A journey through time in cataract surgery.J. Perioper. Pract.202520251750458924126440010.1177/17504589241264400 39803782
    [Google Scholar]
  82. HanG.R. GoncharovA. EryilmazM. Machine learning in point-of-care testing: Innovations, challenges, and opportunities.Nat. Commun.2025161316510.1038/s41467‑025‑58527‑6 40175414
    [Google Scholar]
  83. WahJ.N.K. Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation.J. Robot. Surg.20251914710.1007/s11701‑024‑02205‑0 39776281
    [Google Scholar]
  84. StopyraW. LangenbucherA. GrzybowskiA. Intraocular lens power calculation formulas: A systematic review.Ophthalmol. Ther.20231262881290210.1007/s40123‑023‑00799‑6 37698825
    [Google Scholar]
  85. RyuS. JunI. KimT. KimE.K. SeoK.Y. Accuracy of the kane formula for intraocular lens power calculation in comparison with existing formulas: A retrospective review.Yonsei Med. J.202162121117112410.3349/ymj.2021.62.12.1117 34816642
    [Google Scholar]
  86. TrivediR.H. WernerL. AppleD.J. PandeyS.K. IzakA.M. Post cataract-intraocular lens (IOL) surgery opacification.Eye (Lond.)200216321724110.1038/sj.eye.6700066 12032712
    [Google Scholar]
  87. LuoC. WangH. ChenX. XuJ. YinH. YaoK. Recent advances of intraocular lens materials and surface modification in cataract surgery.Front. Bioeng. Biotechnol.20221091338310.3389/fbioe.2022.913383 35757812
    [Google Scholar]
  88. WangS.Y. StemM.S. OrenG. ShteinR. LichterP.R. Patient-centered and visual quality outcomes of premium cataract surgery: A systematic review.Eur. J. Ophthalmol.201727438740110.5301/ejo.5000978 28574135
    [Google Scholar]
  89. HuF. YangH. QiuL. WeiS. HuH. ZhouH. Spatial structure and organization of the medical device industry urban network in China: Evidence from specialized, refined, distinctive, and innovative firms.Front. Public Health202513151832710.3389/fpubh.2025.1518327 40161027
    [Google Scholar]
  90. HoskinA.K. PhilipS. DainS.J. MackeyD.A. Spectacle‐related eye injuries, spectacle‐impact performance and eye protection.Clin. Exp. Optom.201598320320910.1111/cxo.12283 25963111
    [Google Scholar]
  91. MaJ.J.K. MoradY. MauE. BrentH.P. BarclayR. LevinA.V. Contact lenses for the treatment of pediatric cataracts.Ophthalmology2003110229930510.1016/S0161‑6420(02)01557‑9 12578770
    [Google Scholar]
  92. EfronN. MorganP.B. Rethinking contact lens aftercare.Clin. Exp. Optom.2017100541143110.1111/cxo.12588 28871604
    [Google Scholar]
  93. SalzJ.J. SchlangerJ.L. Prolonged wear soft contact lenses.J. Am. Intraocul. Implant Soc.19806324624810.1016/S0146‑2776(80)80070‑X 7410173
    [Google Scholar]
  94. ZvorničaninJ. ZvorničaninE. Premium intraocular lenses: The past, present and future.J. Curr. Ophthalmol.201830428729610.1016/j.joco.2018.04.003 30555960
    [Google Scholar]
  95. YangL. LiJ. ZhouB. WangY. An injectable copolymer for in situ lubrication effectively relieves dry eye disease.ACS Mater. Lett.20257388489010.1021/acsmaterialslett.4c02327
    [Google Scholar]
  96. NadeemS. Cataract surgery: Historical devices, modern innovations, and future perspectives.Expert Rev. Med. Devices2024211199199410.1080/17434440.2024.2419477 39431615
    [Google Scholar]
  97. SukhijaJ. KaurS. RamJ. Outcome of primary intraocular lens implantation in infants: Complications and rates of additional surgery.J. Cataract Refract. Surg.20164271060106510.1016/j.jcrs.2016.04.028 27492106
    [Google Scholar]
  98. WernerL. Intraocular Lenses.Ophthalmology202112811e74e9310.1016/j.ophtha.2020.06.055 32619547
    [Google Scholar]
  99. KarayilanM. ClamenL. BeckerM.L. Polymeric materials for eye surface and intraocular applications.Biomacromolecules202122222326110.1021/acs.biomac.0c01525 33405900
    [Google Scholar]
  100. PohjalainenT. VestiE. UusitaloR.J. LaatikainenL. Phacoemulsification and intraocular lens implantation in eyes with open‐angle glaucoma.Acta Ophthalmol. Scand.200179331331610.1034/j.1600‑0420.2001.790322.x 11401647
    [Google Scholar]
  101. TanN. ZhengD. YeJ. Comparison of visual performance after implantation of 3 types of intraocular lenses: accommodative, multifocal, and monofocal.Eur. J. Ophthalmol.201424569369810.5301/ejo.5000425 24474378
    [Google Scholar]
  102. WuZ. SunW. WangC. Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis.Invest. New Drugs202442551051710.1007/s10637‑024‑01464‑w 39141261
    [Google Scholar]
  103. AuthorsC. BaileyH.S. CADTH health technology review, intraocular lenses for cataract surgery: CADTH health technology review.Ottawa, ONCanadian Agency for Drugs and Technologies in Health2023
    [Google Scholar]
  104. RamJ. SinghR. GuptaR. BhutaniG. GuptaP.C. SukhijaJ. Toric intraocular lens implantation in children with developmental cataract and preexisting corneal astigmatism.Acta Ophthalmol.2017952e95e10010.1111/aos.13220 27573881
    [Google Scholar]
  105. VacalebreM. FrisonR. CorsaroC. Current state of the art and next generation of materials for a customized intraocular lens according to a patient-specific Eye power.Polymers2023156159010.3390/polym15061590 36987370
    [Google Scholar]
  106. BanhA. BantseevV. ChohV. MoranK.L. SivakJ.G. The lens of the eye as a focusing device and its response to stress.Prog. Retin. Eye Res.200625218920610.1016/j.preteyeres.2005.10.001 16330238
    [Google Scholar]
  107. ZhangK. HeW. DuY. Inhibitory effect of lanosterol on cataractous lens of cynomolgus monkeys using a subconjunctival drug release system.Precis. Clin. Med.202253pbac02110.1093/pcmedi/pbac021 36196296
    [Google Scholar]
  108. Chemerovski-GlikmanM. MimouniM. DaganY. Rosmarinic acid restores complete transparency of sonicated human cataract ex vivo and delays cataract formation in vivo.Sci. Rep.201881934110.1038/s41598‑018‑27516‑9 29921877
    [Google Scholar]
  109. LouM.F. XuG.T. ZiglerS. YorkB. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.Curr. Eye Res.199615442343210.3109/02713689608995833 8670742
    [Google Scholar]
  110. SasakiT. YamakoshiJ. SaitoM. Antioxidative activities of 4-hydroxy-3(2H)-furanones and their anti-cataract effect on spontaneous cataract rat (ICR/f).Biosci. Biotechnol. Biochem.199862101865186910.1271/bbb.62.1865 9836421
    [Google Scholar]
  111. ManikandanR. ThiagarajanR. BeulajaS. SudhandiranG. ArumugamM. Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium.Free Radic. Biol. Med.201048448349210.1016/j.freeradbiomed.2009.11.011 19932168
    [Google Scholar]
  112. MuthennaP. RaghuG. AkileshwariC. SinhaS.N. SuryanarayanaP. ReddyG.B. Inhibition of protein glycation by procyanidin-B2 enriched fraction of cinnamon: Delay of diabetic cataract in rats.IUBMB Life2013651194195010.1002/iub.1214 24136906
    [Google Scholar]
  113. VuJ.T. WangE. WuJ. Calpains as mechanistic drivers and therapeutic targets for ocular disease.Trends Mol. Med.202228864466110.1016/j.molmed.2022.05.007 35641420
    [Google Scholar]
  114. SasikalaV. RoobanB.N. SahasranamamV. AbrahamA. Rutin ameliorates free radical mediated cataract by enhancing the chaperone activity of α-crystallin.Graefes Arch. Clin. Exp. Ophthalmol.201325171747175510.1007/s00417‑013‑2281‑z 23412395
    [Google Scholar]
  115. ChennamaneniSR MamalisC ArcherB OakeyZ AmbatiBK Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation.J Control Release201316753910.1016/j.jconrel.2013.01.007
    [Google Scholar]
  116. Hernandez-MontelongoJ. NaveasN. DegoutinS. Porous silicon-cyclodextrin based polymer composites for drug delivery applications.Carbohydr. Polym.201411023825210.1016/j.carbpol.2014.04.002 24906752
    [Google Scholar]
  117. XuL. QiuW.X. LiuW.L. PLA–PEG micelles loaded with a classic vasodilator for oxidative cataract prevention.ACS Biomater. Sci. Eng.20195240741210.1021/acsbiomaterials.8b01089 33405805
    [Google Scholar]
  118. SharmaU.K. VermaA. PrajapatiS.K. PandeyH. PandeyA.C. In vitro, in vivo and pharmacokinetic assessment of amikacin sulphate laden polymeric nanoparticles meant for controlled ocular drug delivery.Appl. Nanosci.20155214315510.1007/s13204‑014‑0300‑y
    [Google Scholar]
  119. YuF. ZhengM. ZhangA.Y. HanZ. A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.J. Control. Release2019315405410.1016/j.jconrel.2019.10.039
    [Google Scholar]
  120. ZhangJ. WangS. Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: Tolerance, precorneal retention and anti-cataract effect.Int. J. Pharm.20093721-2667510.1016/j.ijpharm.2009.01.001 19437594
    [Google Scholar]
  121. BaşaranE. DemirelM. SırmagülB. YazanY. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery.J. Microencapsul.2010271374710.3109/02652040902846883 19545226
    [Google Scholar]
  122. ZhangW. LiX. YeT. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.Int. J. Pharm.2013454135436610.1016/j.ijpharm.2013.07.032 23876384
    [Google Scholar]
  123. RomanelliL. ValeriP. MorroneL.A. PimpinellaG. GrazianiG. TitaB. Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehicles.Life Sci.1994541387788510.1016/0024‑3205(94)00624‑5 8139376
    [Google Scholar]
  124. GramaC.N. SuryanarayanaP. PatilM.A. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model.PLoS One2013810e7821710.1371/journal.pone.0078217 24155984
    [Google Scholar]
  125. ZengW. LiQ. WanT. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.Colloids Surf. B Biointerfaces2016141283510.1016/j.colsurfb.2016.01.014 26820107
    [Google Scholar]
  126. TayelS.A. El-NabarawiM.A. TadrosM.I. Abd-ElsalamW.H. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.Int. J. Pharm.20134431-229330510.1016/j.ijpharm.2012.12.049 23333217
    [Google Scholar]
  127. GautamD. PedlerM.G. NairD.P. PetrashJ.M. Nanogel-facilitated in-situ delivery of a cataract inhibitor.Biomolecules2021118115010.3390/biom11081150 34439816
    [Google Scholar]
  128. TripathiP AkhterY KhurshidM Understanding, MTCD: Cataract detection via near infrared eye images.arXiv2022
    [Google Scholar]
  129. AllinsonR.W. MetrikinD.C. FanteR.G. Incidence of vitreous loss among third-year residents performing phacoemulsification.Ophthalmology199299572673010.1016/S0161‑6420(92)31904‑9 1594218
    [Google Scholar]
  130. VashistP. SenjamS.S. GuptaV. Blindness and visual impairment and their causes in India: Results of a nationally representative survey.PLoS One2022177e027173610.1371/journal.pone.0271736 35862402
    [Google Scholar]
  131. AlswailmiF.K. Global prevalence and causes of visual impairment with special reference to the general population of Saudi Arabia.Pakistan J. Med. Sci.2018343751756
    [Google Scholar]
  132. TsaiC.H. WangP.Y. LinI.C. HuangH. LiuG.S. TsengC.L. Ocular drug delivery: Role of degradable polymeric nanocarriers for ophthalmic application.Int. J. Mol. Sci.2018199283010.3390/ijms19092830 30235809
    [Google Scholar]
  133. MusaI. BansalS. KaleemM.A. Barriers to care in the treatment of glaucoma: Socioeconomic nlms that impact the diagnosis, treatment, and outcomes in glaucoma patients.Curr. Ophthalmol. Rep.2022103859010.1007/s40135‑022‑00292‑6 35911786
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128409580250812000816
Loading
/content/journals/cpd/10.2174/0113816128409580250812000816
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): Cataract; couching; dropless; femtosecond laser; intraocular lenses; phacoemulsification
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test